Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases

Anti-tumor necrosis factor (TNF) antibodies are successfully used in the therapy of inflammatory bowel diseases (IBD). However, the molecular mechanism of action of these agents is still a matter of debate. Apart from neutralization of TNF, influence on the intestinal barrier function, induction of...

Descripción completa

Detalles Bibliográficos
Autores principales: Billmeier, Ulrike, Dieterich, Walburga, Neurath, Markus F, Atreya, Raja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107694/
https://www.ncbi.nlm.nih.gov/pubmed/27895418
http://dx.doi.org/10.3748/wjg.v22.i42.9300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107694/
https://www.ncbi.nlm.nih.gov/pubmed/27895418
http://dx.doi.org/10.3748/wjg.v22.i42.9300

Ejemplares similares